How do AF comorbidity patterns change care and outcomes?
In 32,560 AF patients, six comorbidity phenotypes ranged from low complexity to high complexity, with cardiometabolic/high-complexity groups facing higher event risk despite more anticoagulation.
Source
Patterns of comorbidities in patients with atrial fibrillation and impact on management and long-term prognosis: an analysis from the Prospective Global GLORIA-AF Registry
Study at a glance
- Design
- Cohort — Prospective Global GLORIA-AF Registry comorbidity phenotype analysis
- N
- N=32560 · AF patients; mean age 70.0 ± 10.5 years; 45.4% female
- Population
- Adults with atrial fibrillation in a global prospective registry
- Outcome
- Comorbidity phenotypes linked to management and long-term prognosis
Structured fields used in claim comparison tables when every cited study has a complete layer.
Inspect source passages
How do AF comorbidity patterns change care and outcomes?
These passages occur verbatim in the stored paper text. They support the points listed below; they do not verify every statement in the explanation.
32,560 AF patients included.
Results 32,560 AF patients (mean age 70.0 ± 10.5 years, 45.4% females) were included.
Low complexity was 39.2% of patients.
We identified 6 phenotypes: (i) low complexity (39.2% of patients); (ii) cardiovascular (CV) risk factors (28.2%); (iii) atherosclerotic (10.2%); (iv) thromboembolic (8.1%); (v) cardiometabolic (7.6%) and (vi) high complexity (6.6%).
What they did
Analyzed the Prospective Global GLORIA-AF Registry to cluster comorbidity phenotypes and relate them to oral anticoagulant/rate-control use and long-term primary outcomes.
What they found
Six phenotypes: low complexity (39.2%), CV risk factors (28.2%), atherosclerotic (10.2%), thromboembolic (8.1%), cardiometabolic (7.6%), high complexity (6.6%). More complex groups used more OACs; cardiometabolic and high-complexity groups had the highest primary-outcome HRs (~1.37 and ~1.47).
The limits
What it doesn't show
Registry observational associations cannot prove that changing phenotype classification improves outcomes; residual confounding and regional practice variation remain.
Key terms
- Atrial fibrillation
- Irregular atrial rhythm with stroke and heart-failure risk.
- Multimorbidity
- Two or more concurrent chronic conditions.
- Clinical complexity
- Interplay of multimorbidity, ageing, frailty, polypharmacy.
- Phenotype
- Clustered comorbidity pattern within AF patients.
- GLORIA-AF
- Global prospective AF registry.
- Oral anticoagulant
- Medication used for stroke prevention in AF.
Flashcards
0 of 8 answers reviewed
Research intelligence for this paper
See its role on concept claims, tensions it is part of, placement history, and related discoveries.
Quiz yourself
GLORIA-AF analytic N?
Common questions
N?
32,560 AF patients.
Largest phenotype?
Low complexity (39.2%).
Highest-risk phenotypes?
Cardiometabolic and high complexity.
OAC use pattern?
Higher in more complex groups.
More on Cardiovascular